Marshall Wace, LLP Sab Biotherapeutics Inc Wt Exp Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Marshall Wace, LLP holds 247,576 shares of SABSW stock, worth $17,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247,576Holding current value
$17,330% of portfolio
0.0%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding SABSW
# of Institutions
12Shares Held
621KCall Options Held
602KPut Options Held
0-
Hb Wealth Management, LLC310KShares$21,7000.0% of portfolio
-
Morgan Stanley New York, NY146KShares$10,2500.0% of portfolio
-
Yakira Capital Management, Inc. Westport, CT108KShares$7,5930.0% of portfolio
-
Walleye Capital LLC Plymouth, MN23.3KShares$1,6280.0% of portfolio
-
Wolverine Asset Management LLC15.5KShares$1,0860.0% of portfolio
About SAB BIOTHERAPEUTICS INC WT EXP
- Ticker SABSW
- Sector Healthcare
- Industry Biotechnology